Immunohistochemical localisation of pre-synaptic muscarinic receptor subtype-2 (M2r) in the enteric nervous system of guinea-pig ileum.
The cholinergic muscarinic 2 receptor (M2r) is known to be present on smooth muscle cells in the intestine. Pharmacological studies also suggest that M2rs regulate transmitter release from nerves in the enteric nervous system. This study localised M2rs in the guinea-pig ileum using different antibodies and fluorescence immunohistochemistry. Double labelling with antibodies against neurochemical markers was used to identify the type of nerves bearing M2r. Guinea-pig ileum were fixed, prepared for sections and wholemounts and incubated with antisera against the M2r sequence. Tissue was double labelled with antibodies against neuronal nitric oxide synthase (nNOS), common choline acetyltransferase (cChAT), substance P (SP), synaptophysin and vesicular acetylcholine transporter (VAChT). Immunofluorescence was viewed using confocal microscopy. Abundant M2r-immunoreactivity (IR) was present on the surface of circular and longitudinal smooth muscle cells. M2r-IR was present in many but not all nerve fibres in the circular muscle and ganglia. M2r-IR was present in VAChT-IR and cChAT-IR cholinergic nerve fibres and SP-IR nerve fibres in the myenteric ganglia and submucosal ganglia. M2r-IR was present on a few nNOS-IR nerve fibres and around nNOS-IR neurons in the myenteric ganglia. In the circular muscle and deep muscular plexus, M2r-IR was present in many VAChT-IR and SP-IR nerve fibres and in few nNOS-IR nerves. M2rs are not only present on muscle cells in the intestine, but also on nerve fibres. M2rs may mediate cholinergic reflexes via their location on muscle and also via neural transmission. The pre-synaptic location supports pharmacological studies suggesting M2rs mediate neurotransmitter release from nerve fibres. The presence of M2rs on VAChT-IR, SP-IR and nNOS-IR-containing nerve fibres suggests M2rs may regulate ACh, SP and nitric oxide release.
Harrington
A M
AM
Surgical Research and Gut Motility Laboratory, Murdoch Children's Research Institute, Royal Children's Hospital, Level 8, AP Building, Parkville, 3052, Australia.
Hutson
J M
JM
Southwell
B R
BR
D000818:Animals; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D002799:Cholinergic Fibers / Q000378:metabolism; D017615:Enteric Nervous System / Q000166:cytology / Q000378:metabolism*; D005725:Ganglia, Autonomic / Q000166:cytology / Q000378:metabolism; D006168:Guinea Pigs; D007082:Ileum / Q000166:cytology / Q000294:innervation* / Q000378:metabolism; D007150:Immunohistochemistry; D009130:Muscle, Smooth / Q000166:cytology / Q000294:innervation / Q000378:metabolism; D032389:Myocytes, Smooth Muscle / Q000378:metabolism; D009412:Nerve Fibers / Q000378:metabolism; D026602:Nitrergic Neurons / Q000166:cytology / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism; D017729:Presynaptic Terminals / Q000378:metabolism*; D043585:Receptor, Muscarinic M2 / Q000378:metabolism*; D013373:Substance P / Q000378:metabolism; D016708:Synaptophysin / Q000378:metabolism; D050494:Vesicular Acetylcholine Transport Proteins / Q000378:metabolism
D043585:Receptor, Muscarinic M2; D016708:Synaptophysin; D050494:Vesicular Acetylcholine Transport Proteins; D013373:Substance P; D052248:Nitric Oxide Synthase Type I; D002795:Choline O-Acetyltransferase